Ameritas Advisory Services’s Aehr Test Systems AEHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-140
Closed -$1.81K 2113
2025
Q2
$1.81K Buy
+140
New +$1.33K ﹤0.01% 2506
2023
Q2
Sell
-1,000
Closed -$31K 577
2023
Q1
$31K Buy
+1,000
New +$32.2K ﹤0.01% 1447
2022
Q4
Sell
-470,283
Closed -$6.63M 880
2022
Q3
$6.63M Buy
470,283
+46,636
+11% +$628K 0.4% 51
2022
Q2
$3.18M Buy
423,647
+59,100
+16% +$491K 0.18% 121
2022
Q1
$3.7M Buy
364,547
+158,500
+77% +$2.03M 0.14% 121
2021
Q4
$4.98M Buy
+206,047
New +$4.03M 0.18% 93

Other funds holding AEHR

Ameritas Advisory Services's AEHR Position: Q3 2025 in Review

Ameritas Advisory Services sold out of Aehr Test Systems (AEHR) in Q3 2025, closing a stake of 140 shares — an estimated $1.81K sold.

Ameritas Advisory Services first reported a position in AEHR in Q4 2021 and held it in 6 quarters. The position peaked at $6.63M in Q3 2022. 149 funds tracked by Wall St. Rank hold AEHR as of Q3 2025.

  • Ameritas Advisory Services reported no remaining Aehr Test Systems position as of Q3 2025 after selling out during the quarter.
  • Ameritas Advisory Services sold 140 Aehr Test Systems shares in Q3 2025, an estimated $1.81K.
  • Ameritas Advisory Services first reported a position in Aehr Test Systems in Q4 2021 and held it in 6 quarters.
  • Ameritas Advisory Services's Aehr Test Systems position peaked at $6.63M in Q3 2022.
  • 149 funds tracked by Wall St. Rank held Aehr Test Systems as of Q3 2025.

Based on Ameritas Advisory Services's 13F filing for Q3 2025, filed 6 Nov 2025.